Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
This grant opportunity aims to support projects that use nanotechnology to tackle significant obstacles in cancer biology and oncology. It focuses on research that enhances the fundamental understanding of how nanomaterials and nano-devices interact with biological systems. Key areas include the delivery of nanoparticles or nano-devices to targeted cancer sites within the body and the characte…
Through this Notice of Funding Opportunity (NOFO) entitled "Innovative Research in Cancer Nanotechnology (IRCN)", the National Cancer Institute (NCI) intends to expand the fundamental understanding of the processes pertinent to the use of nanotechnology in cancer. The goal of IRCN projects is to…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply as the applicant organization. Foreign components, as defined in the NIH Grants Policy Statemen…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers